Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04012775Phase 3Completed
A Phase 3 trial of insulin isophane in type 2 diabetes mellitus (T2DM), sponsored by Geropharm. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04012775.